Its a long wait for a monkeypox vaccine in San Francisco."I arrived here at 7:30 in the morning, so it's been three and a half hours right now," said Parind Shah, a San Francisco resident. The wait for the antiviral drug to treat monkeypox is drawn out, too."We don't have an equitable system to really distribute them because they require so much paperwork," said Dr. Peter Chin-Hong, an infectious disease specialist at UCSF. The medication is called tecovirimat, with the brand name TPOXX.Dr. Chin-Hong cares for severe monkeypox patients. "It works by the envelope of the virus," Dr. Chin-Hong said. "It disrupts the envelope. Monkeypox virus is a very straightforward virus. It's not complicated with spikes like COVID."Theres not a shortage of TPOXX, but its only FDA-approved for smallpox. For monkeypox, its still considered an investigational drug.  The CDC has lifted some requirements, so doctors can prescribe it under something called expanded access. But that involves hours of forms and extra appointments.Dr. Chin-Hong has seen it deter patients.  "He said, 'Oh, you know, it's okay. I don't want to come in, go through all this paperwork again. I think I'm just going to deal with pain. And you know what? You are asking me too many questions. I'll let you know if i need it,'" Dr. Chin-Hong said.The latest CDC data from late July show doctors wrote about 230 TPOXX prescriptions  for monkeypox. Since then, cases have more than doubled.The CDC says monkeypox spreads when a person touches the skin of someone who is infected and is showing symptoms, like sores or scabs. It can also spread through respiratory droplets or oral fluids in close, intimate contact.You can also get monkeypox from touching recently contaminated clothing or bedding used by an infected person who has symptoms."We are seeing lesions erupt that are very small," said Dr. Jason Farley, infectious disease nurse epidemiologist at The Johns Hopkins School of Medicine. "They're deeply seated, possibly under the skin, maybe look like a pimple that is forming."If you fit any of those descriptions, health experts say call your doctor for a test as soon as you can, because antivirals like TPOXX work best when taken early into illness.That's where public health emergencies come in. Declaring one frees up money in reserves that cant be touched, and HHS rules wont let providers dip from their COVID emergency funds for monkeypox. Dr. Chin-Hong says for TPOXX, that means more help on that extra paperwork so he can care for more sick patients.

WASHINGTON (AP) — The U.S. will declare a public health emergency to bolster the federal response to the outbreak of monkeypox that already has infected more than 6,600 Americans, two people familiar with the matter said Thursday.

The announcement will free up federal funding and resources to fight the virus, which may cause fever, body aches, chills, fatigue and pimple-like bumps on many parts of the body. The people spoke on the condition of anonymity ahead of the announcement.

The declaration comes as the the Biden administration has faced criticism over the pace of vaccine availability for monkeypox. Clinics in major cities like New York and San Francisco say they haven’t received enough of the two-shot vaccine to meet demand and some have had to stop offering the second dose of the vaccine to ensure supply of first doses. The White House said it has made more than 1.1 million doses of vaccine available and has helped to boost domestic diagnostic capacity to 80,000 tests per week.

Get more information here:

Listen now and subscribe: Apple Podcasts | Google Podcasts | Spotify | RSS Feed | Omny Studio


Become a #ThisIsTucson member! Your contribution helps our team bring you stories that keep you connected to the community. Become a member today.